Loading provider…
Loading provider…
Rheumatology Physician in Minneapolis, MN
NPI: 1235147331Primary Practice Location
MINNEAPOLIS VA MEDICAL CENTER
1 Veterans Dr, Minneapolis, MN
Primary Employer
Minneapolis VA Health Care System
va.gov
HQ Phone
Get MD Jerry's Phone Numberphone_androidMobile
Get MD Jerry's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
MN State Medical License
2007 - 2026
WA State Medical License
1997 - 2008

American Board of Internal Medicine
Rheumatology
Carver College of Medicine
medicine.uiowa.edu
Medical School
Until 1993
University of Washington
Fellowship • Rheumatology
1997 - 1999
Residency • Internal Medicine
1994 - 1997
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 47 | 66 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 21 | 27 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 11 | 20 |
Can Large Simple Trials Help Us Understand When and How to Use Generic Drugs for Uncommon Diseases
Authors: Jerry A. Molitor, David L. DeMets
Publication Date: 2013-05
Authors: Tracy Frech, Shervin Assassi, Xiaodong Zhou, Maureen Mayes, Daniel Furst, Miranda Taing, Laura Hummers, Monique Hinchcliff, Malahat Movahedian
Journal: Arthritis Res Ther
Publication Date: 2016-01-20
Authors: Jane Buckner
Journal: Arthritis Rheum
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Immune Tolerance Network (ITN), PPD Development, LP, Seagen Inc., Rho Federal Systems Division, Inc.
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: Brentuximab Vedotin
Lead Sponsor: Dinesh Khanna, MD, MS
Collaborators: Bristol-Myers Squibb, National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Placebo, DRUG: Abatacept
Lead Sponsor: Kadmon, a Sanofi Company
Intervention / Treatment: DRUG: Placebo, DRUG: Belumosudil (KD025)